8-K: Seritage Growth Properties Q3 2025: Asset Sales & Debt Reduction

Seritage Growth Properties reports Q3 2025 results, highlighting significant asset sales under contract and plans for a substantial Term Loan Facility prepayment.

Summary

• Net loss attributable to common shareholders was ($13.6) million, or ($0.24) per share, for the three months ended September 30, 2025.
• Net Operating Income-cash basis at share (NOI-cash basis at share) was $1.6 million for the three months ended September 30, 2025.
• For the nine months ended September 30, 2025, net loss attributable to common shareholders was ($66.8) million, or ($1.19) per share.
• For the nine months ended September 30, 2025, NOI-cash basis at share was $6.8 million.
• As of November 13, 2025, four assets are under contract for anticipated gross proceeds of $240.8 million, with three of these totaling $170.0 million having no due diligence contingencies.
• The company is negotiating definitive purchase agreements for three joint venture assets, which could result in anticipated gross distributions of approximately $47.3 million.
• Cash on hand was $59.9 million as of September 30, 2025, increasing to $65.0 million by November 13, 2025, including $8.3 million of restricted cash.
• The Term Loan Facility maturity date was extended to July 31, 2026, after paying a 2% extension fee of $4.0 million and an incremental facility fee of $4.0 million on the $200 million outstanding principal balance.
• Impairment charges of $0.8 million were recognized in Q3 2025 and $18.8 million for the nine months ended September 30, 2025, on consolidated properties.
• The company made $40.0 million in principal repayments on the Term Loan Facility during the nine months ended September 30, 2025.
• The portfolio consists of interests in 13 properties (approximately 1.3 million square feet of GLA and 198 acres) as of September 30, 2025.
• Multi-Tenant Retail properties are 92.0% leased (391 thousand square feet) with a Gross Annual Base Rent (ABR) per square foot of $18.25.
• Premier Mixed-Use properties are 69.7% leased (265.7 thousand square feet at share) with an ABR per square foot of $73.16.

Sentiment

Score: 6

Explanation: The company shows positive momentum with significant asset sales under contract and plans for debt reduction, leading to improved Q3 financial metrics compared to the prior year. However, persistent net losses, substantial impairment charges, ongoing complex litigation, and challenging market conditions introduce considerable uncertainty. The decision to cease providing future sales projections also reduces transparency, balancing the positive developments with notable risks and challenges.

Positives

• Four assets are under contract for anticipated gross proceeds of $240.8 million, with $170.0 million having no due diligence contingencies, indicating significant progress on the Plan of Sale.
• Expects near-term closings for three assets under contract, which would allow for a sizeable prepayment of the Term Loan Facility outstanding principal balance prior to year-end.
• Negotiating definitive purchase agreements on three joint venture assets, potentially yielding approximately $47.3 million in gross distributions.
• Cash on hand increased from $59.9 million as of September 30, 2025, to $65.0 million as of November 13, 2025.
• Net loss attributable to common shareholders decreased to ($13.6) million in Q3 2025 from ($23.2) million in Q3 2024.
• NOI-cash basis at share improved to $1.6 million in Q3 2025 from ($934) thousand in Q3 2024.
• Made $40.0 million in principal repayments on the Term Loan Facility during the nine months ended September 30, 2025.

Negatives

• Continued net loss attributable to common shareholders of ($13.6) million for Q3 2025 and ($66.8) million for the nine months ended September 30, 2025.
• Recognized impairment charges of $0.8 million in Q3 2025 and $18.8 million for the nine months ended September 30, 2025, on consolidated properties.
• Paid a $4.0 million extension fee and a $4.0 million incremental facility fee for the Term Loan Facility extension.
• One premier development asset under contract for $70.8 million is subject to a due diligence contingency and a long-dated closing.
• Ongoing class action lawsuit and multiple derivative lawsuits alleging federal securities law violations and breach of fiduciary duty against the company and its management.
• The company will no longer provide future sales projections, citing potential adverse impact on marketing efforts for remaining assets.

Risks

• Challenging market conditions, including elevated interest rates and limited availability of debt and equity capital, could apply downward pricing pressures on remaining assets.
• There is no assurance that asset sales will be consummated or that funding from sales will be available to meet liquidity needs.
• Risks associated with redevelopment activities and contingencies to the commencement of rent under leases.
• Failure to achieve expected occupancy and/or rent levels within projected timeframes or at all.
• The impact of ongoing negative operating cash flow on the company's ability to fund operations and ongoing development.
• The company's ability to access or obtain sufficient sources of financing to fund its liquidity needs.
• Environmental, health, safety, and land use laws and regulations.
• Possible acts of war, terrorist activity, or other acts of violence or cybersecurity incidents.
• Ongoing litigation, including a class action lawsuit and several derivative lawsuits, could result in significant compensatory damages and legal expenses.
• Actual results may differ materially from sales projections until closings are consummated.

Future Outlook

The company expects near-term closings for three assets under contract with no due diligence contingencies, which, if completed, would allow for a sizeable prepayment of the Term Loan Facility prior to year-end. All but six of the remaining assets are either under contract or in PSA negotiations. The remaining six assets are expected to be marketed in 2026 and beyond, with estimated gross sales proceeds for these assets ranging from $220 million to $310 million. The company will no longer provide future sales projections in any form, citing potential adverse impacts on marketing efforts. Challenging market conditions, including elevated interest rates and limited capital availability, are expected to continue to adversely impact the proceeds from the Plan of Sale and the timing of distributions to shareholders. The strategic review process for the Plan of Sale is ongoing, and the company remains open to pursuing value-maximizing alternatives, including a potential sale of the company.

Management Comments

• "We continue to see good progress on our various asset sale processes. While not guaranteed, we currently expect to see near-term closings for all three assets under contract with no due diligence contingencies, which, if completed, would allow us to make a sizeable prepayment of our Term Loan Facility outstanding principal balance prior to year end."

Industry Context

The real estate industry continues to navigate a challenging environment characterized by elevated interest rates and reduced availability of debt and equity capital. This impacts property valuations, development financing, and the overall pace of transactions. Seritage's ongoing strategy of divesting assets and reducing debt aligns with a cautious approach in such a market, prioritizing liquidity and capital structure optimization. The decision to discontinue detailed future sales projections reflects the sensitivity of asset disposition in competitive and uncertain market conditions.

Corporate Governance

Legal Proceedings

• A class action lawsuit (Zhengxu He, Trustee of the He & Fang 2005 Revocable Living Trust v. Seritage Growth Properties, Case No. 1:24:CV:05007) was filed on July 1, 2024, alleging violations of federal securities laws due to false, misleading, and/or omissive disclosures concerning internal controls for impairment indicators and asset valuations. It seeks compensatory damages.
• Multiple derivative lawsuits (Paul Sidhu v. Seritage Growth Properties, Case No. 1:25-cv-00152; James Wallen v. Seritage Growth Properties, Case No. 1:25-cv-00190; Derrick Cheroti v. Seritage Growth Properties, Case No. 1:25-vc-00152) were filed between January and May 2025. These actions allege breach of fiduciary duty and other claims against the company's CEO, CFO, and current/former Board members, based on similar claimed acts and omissions as the Securities Action. They seek compensatory damages, corporate governance reforms, restitution, and an award of costs and fees.
• The Sidhu and Wallen derivative actions were consolidated into the "Consolidated Derivative Action" on November 5, 2025, and subsequently stayed on November 12, 2025, pending resolution of the anticipated motion to dismiss in the Securities Action.
• The Cheroti Derivative Action was stayed on September 2, 2025, pending resolution of the anticipated motion to dismiss in the Securities Action.
• The Company intends to vigorously defend itself against the allegations in these lawsuits.

Stakeholder Impact

• **Shareholders**: Potential for future distributions from asset sales, but timing and amounts remain uncertain due to market conditions and ongoing litigation. Preferred shareholders continue to receive dividends. Common shareholders face ongoing net losses and the inherent risks associated with a company executing a Plan of Sale.
• **Creditors (Term Loan Facility holders)**: The expected sizeable prepayment of the Term Loan Facility is positive, reducing the company's debt exposure. The extension of the maturity date to July 31, 2026, provides additional time for asset dispositions to fund repayments.
• **Customers (Tenants)**: Continued leasing activity in Multi-Tenant Retail (92% leased) and Premier Mixed-Use (69.7% leased) indicates ongoing operations, but the overall divestment strategy suggests a changing landlord relationship over time as properties are sold.

Next Steps

• Complete near-term closings for the three assets under contract with no due diligence contingencies.
• Make a sizeable prepayment of the Term Loan Facility outstanding principal balance prior to year-end.
• Negotiate and execute definitive purchase and sale agreements for the three joint venture assets.
• Market the remaining six assets at the appropriate time based on market conditions, with sales anticipated in 2026 and beyond.
• Vigorously defend against the allegations in the class action and derivative lawsuits.
• Continue executing the Plan of Sale and remain open to value-maximizing alternatives, including a potential sale of the company.
• Pay the declared preferred stock dividend on January 15, 2026, to holders of record on December 31, 2025.

Key Dates

Recommendation

While Seritage Growth Properties is making tangible progress on its Plan of Sale with significant assets under contract and a clear intention to reduce debt, the company continues to report net losses and incur substantial impairment charges. The ongoing, complex litigation introduces considerable uncertainty and potential financial liabilities. Furthermore, the decision to cease providing future sales projections reduces transparency for investors. The positive steps are balanced by these persistent challenges and the prevailing difficult market conditions, suggesting a 'hold' position until there is clearer resolution on the litigation, more certainty on the remaining asset sales, and a path to sustained profitability.

Keywords

Real Estate, Asset Sales, Debt Reduction, Q3 2025 Results, Seritage Growth Properties, SRG, REIT, Property Development, Financial Performance, Litigation, Impairment Charges, Term Loan Facility, Corporate Governance